DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 129 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,566,467 | -10.1% | 4,368,433 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $61,843,162 | -13.2% | 4,392,270 | -4.7% | 0.00% | -50.0% |
| Q1 2023 | $71,241,341 | -8.4% | 4,611,090 | -2.8% | 0.00% | 0.0% |
| Q4 2022 | $77,775,811 | -12.3% | 4,745,321 | -1.0% | 0.00% | -33.3% |
| Q3 2022 | $88,708,000 | +53.6% | 4,794,993 | +9.2% | 0.00% | +50.0% |
| Q2 2022 | $57,768,000 | +73.4% | 4,392,946 | +22.2% | 0.00% | +100.0% |
| Q1 2022 | $33,321,000 | -1.7% | 3,594,512 | +3.6% | 0.00% | 0.0% |
| Q4 2021 | $33,895,000 | -74.7% | 3,469,317 | -11.9% | 0.00% | -66.7% |
| Q3 2021 | $133,758,000 | -7.0% | 3,936,385 | +0.2% | 0.00% | -25.0% |
| Q2 2021 | $143,794,000 | -18.8% | 3,927,704 | -0.5% | 0.00% | -20.0% |
| Q1 2021 | $177,032,000 | -19.1% | 3,948,062 | +2.9% | 0.01% | -16.7% |
| Q4 2020 | $218,907,000 | +13.1% | 3,835,758 | +1.6% | 0.01% | 0.0% |
| Q3 2020 | $193,620,000 | -8.7% | 3,774,261 | +6.3% | 0.01% | -25.0% |
| Q2 2020 | $211,980,000 | +104.7% | 3,549,561 | +41.1% | 0.01% | +100.0% |
| Q1 2020 | $103,541,000 | -24.4% | 2,514,972 | +14.3% | 0.00% | -20.0% |
| Q4 2019 | $136,975,000 | +179.6% | 2,200,761 | +52.5% | 0.01% | +150.0% |
| Q3 2019 | $48,984,000 | +174.1% | 1,443,234 | +82.1% | 0.00% | +100.0% |
| Q2 2019 | $17,874,000 | -0.3% | 792,654 | +2.6% | 0.00% | 0.0% |
| Q1 2019 | $17,927,000 | +19.8% | 772,402 | +8.3% | 0.00% | 0.0% |
| Q4 2018 | $14,970,000 | -42.8% | 713,162 | +5.6% | 0.00% | 0.0% |
| Q3 2018 | $26,156,000 | +0.5% | 675,517 | +2.1% | 0.00% | 0.0% |
| Q2 2018 | $26,027,000 | +298.5% | 661,436 | +103.0% | 0.00% | – |
| Q1 2018 | $6,531,000 | -0.9% | 325,883 | +12.1% | 0.00% | – |
| Q4 2017 | $6,589,000 | +90.7% | 290,658 | +59.7% | 0.00% | – |
| Q3 2017 | $3,456,000 | – | 182,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |